HealthcareMcKesson slips as Q2 outlook underwhelmsBy Helitra.com·September 6, 2024·1 min read McKesson slips as Q2 outlook underwhelms Source: SeekingalphaADVERTISEMENT ADVERTISEMENTMcKesson outlook slips underwhelms Post navigation Previous storyPerspective gets FDA fast track status for radiopharmaceutical VMT01Next storyAbbott launches over-the-counter glucose monitor, Lingo
Fitness · HealthcareCan Strength Training Protect Muscle During Weight-Loss Medication Use?November 11, 2026Weight-loss medications have become increasingly popular, particularly with the growing use of GLP-1-based treatments such as semaglutide and tirzepatide. While these medications have…
Fitness · HealthcareWant to ditch fluoride? Dentists explain who might benefit from hydroxyapatite toothpasteNovember 11, 2026For decades, fluoride has ruled the toothpaste aisle, but the tubes, they are a-changin’. Now, a mineral called hydroxyapatite is gaining traction as…
Fitness · HealthcareGLP-1s May Help With More Than Food CravingsNovember 11, 2026GLP-1 medications have changed how doctors treat obesity and diabetes. But their effects may extend beyond blood sugar and appetite. Think about how…